The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
EDEN (Etude Désescalade sEmiNome): Prospective therapeutic de-escalation and miRNA-M371 biomarker evaluation phase II study for stage IIa/IIb < 3 cm seminomas.
 
Armelle Vinceneux
Travel, Accommodations, Expenses - Astellas Pharma; Pfizer
 
David Pasquier
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen
 
Ellen Blanc
No Relationships to Disclose
 
Valéry Attignon
No Relationships to Disclose
 
Pierre Blanchard
Honoraria - Astellas Pharma; Bayer; Boston Pharmaceuticals; Bristol-Myers Squibb; Janssen; MSD
Consulting or Advisory Role - Astellas Pharma; Bayer; Boston Pharmaceuticals; Bristol-Myers Squibb; Janssen; MSD
Speakers' Bureau - Astellas Pharma; Bayer; Boston Pharmaceuticals; Bristol-Myers Squibb; Janssen; MSD
 
Aude Flechon
Honoraria - AAA HealthCare; Astellas Pharma; AstraZeneca; Bayer; BMS; Ipsen; Janssen-Cilag; MSD Oncology; PFIZER; Roche/Genentech; Sanofi/Aventis
Travel, Accommodations, Expenses - AAA HealthCare; Astellas Pharma; AstraZeneca; Bayer; BMS; IPSEN; Janssen-Cilag; MSD Oncology; Pfizer; Roche/Genentech; Sanofi/Aventis